Effect of atropine 0.01% on myopia control in children aged 6-13 years during the 2022 lockdown in Shanghai
- PMID: 36778567
- PMCID: PMC9909278
- DOI: 10.3389/fpubh.2023.1074272
Effect of atropine 0.01% on myopia control in children aged 6-13 years during the 2022 lockdown in Shanghai
Abstract
Purpose: To compare the myopic progression in children treated with 0. 01% atropine and those who discontinued atropine during the 2022-home quarantine in Shanghai.
Methods: In this retrospective study, children aged 6-13 years with follow-up visits before (between January 2022 and February 2022) and after the lockdown (between July 2022 and August 2022) were included. Cycloplegic refraction and axial length (AL) were measured at both visits. The atropine group had continuous medication during the lockdown while the control group discontinued. The 0.01% atropine eyedrops were administered daily before bedtime. The types of spectacle lens were recorded: single vision (SV) spectacles or defocus incorporated multiple segments lenses (DIMS).
Results: In total, 41 children (81 eyes) in the atropine group and 32 children (64 eyes) in the control group were enrolled. No significant difference was found in the demographic characteristics, spherical diopter, spherical equivalent (SE), AL, and follow-up time between the two groups before the lockdown in 2022 (all p > 0.1). After the home confinement, a greater myopia progression was observed in the control group (-0.46 ± 0.42 D) compared to atropine group (-0.26 ± 0.37 D; p = 0.0023). Axial elongation was also longer in the control group than that in children sustained with atropine (0.21 ± 0.17 vs. 0.13 ± 0.15 mm, p = 0.0035). Moreover, there was no significant change of spherical diopter and SE during lockdown in the atropine + DIMS combined subgroup (0.03 ± 0.033 D for spherical diopter, p = 0.7261 and 0.08 ± 0.27 D for SE, p = 0.2042, respectively). However, significant myopic shift was observed in the atropine + SV subgroup during the quarantine time (-0.31 ± 0.39 D for SE and 0.15 ± 0.16 mm for AL, both p < 0.001).
Conclusion: Children treated with 0.01% atropine had slower myopia progression during the lockdown period in Shanghai compared with children discontinued. Moreover, the effect of atropine on myopic prevention can be strengthened with DIMS lenses.
Keywords: COVID-19; Shanghai; atropine; children; defocus incorporated multiple segments (DIMS); myopia control; myopia progression; quarantine.
Copyright © 2023 Yu, Jiang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Myopia control: short-term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses-a retrospective study in European children.Int Ophthalmol. 2023 Oct;43(10):3777-3784. doi: 10.1007/s10792-023-02788-x. Epub 2023 Jul 7. Int Ophthalmol. 2023. PMID: 37420123 Free PMC article.
-
Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents.Eye (Lond). 2024 Jun;38(9):1660-1667. doi: 10.1038/s41433-024-02987-5. Epub 2024 Feb 28. Eye (Lond). 2024. PMID: 38418604 Free PMC article.
-
A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine.PLoS One. 2023 Feb 16;18(2):e0281816. doi: 10.1371/journal.pone.0281816. eCollection 2023. PLoS One. 2023. PMID: 36795775 Free PMC article. Clinical Trial.
-
Interventions to slow progression of myopia in children.Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD004916. doi: 10.1002/14651858.CD004916.pub4. Cochrane Database Syst Rev. 2020. PMID: 31930781 Free PMC article.
-
[Atropine for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines].Klin Monbl Augenheilkd. 2018 Apr;235(4):385-391. doi: 10.1055/s-0043-121982. Epub 2017 Dec 21. Klin Monbl Augenheilkd. 2018. PMID: 29270929 Review. German.
Cited by
-
Short-term effects of ophthalmic topical 0.01% atropine on the ocular surface, pupil size, and subsequent subjective quality of vision in young myopic Chinese adults.Front Med (Lausanne). 2024 Sep 5;11:1436551. doi: 10.3389/fmed.2024.1436551. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39301485 Free PMC article.
-
Myopia progression after cessation of atropine in children: a systematic review and meta-analysis.Front Pharmacol. 2024 Jan 22;15:1343698. doi: 10.3389/fphar.2024.1343698. eCollection 2024. Front Pharmacol. 2024. PMID: 38318144 Free PMC article.
-
The Daily and Two-Day Usage of Low-Dose Atropine on Myopic Control in a Low-Myopia Population.J Clin Med. 2025 May 15;14(10):3458. doi: 10.3390/jcm14103458. J Clin Med. 2025. PMID: 40429453 Free PMC article.
-
Efficacy of the DRL orthokeratology lens in slowing axial elongation in French children.Front Med (Lausanne). 2024 Jan 4;10:1323851. doi: 10.3389/fmed.2023.1323851. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38239610 Free PMC article.
-
The optimal atropine concentration for myopia control in Chinese children: a systematic review and network Meta-analysis.Int J Ophthalmol. 2024 Jun 18;17(6):1128-1137. doi: 10.18240/ijo.2024.06.19. eCollection 2024. Int J Ophthalmol. 2024. PMID: 38895669 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources